Evidence map›Paper›PMID 22253734›Full record

ArticlePloS one2012

Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells.

Glauber de S Araujo, Fernanda L Fonseca, Bruno Pontes, Andre Torres, Radames J B Cordero, Rosely M Zancopé-Oliveira, Arturo Casadevall, Nathan B Viana, Leonardo Nimrichter, Marcio L Rodrigues and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. The Role of Nutritional Environment inInfectious disease reports · 2025
    Article
  3. OptimizingmSphere · 2025
    Article
  4. Article
  5. Divergent paths:Current medical mycology · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. The Dynamics ofCells · 2022
    Article
  10. Article
  11. Ultrastructural Study ofFrontiers in microbiology · 2021
    Article
  12. Comparison ofFrontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Article
  15. Animal Models ofFrontiers in immunology · 2020
    Review
  16. Mediators of inflammation · 2020
    Article
  17. The mechanical properties of microbial surfaces and biofilms.Cell surface (Amsterdam, Netherlands) · 2019
    Article
  18. Article
  19. Clinical Aspects of Immune Damage in Cryptococcosis.Current fungal infection reports · 2019
    Article
  20. The 'Amoeboid Predator-Fungal Animal Virulence' Hypothesis.Journal of fungi (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Glauber de S AraujoLaboratório de Biotecnologia, Instituto Nacional de Metrologia, Normalização e Qualidade Industrial, Rio de Janeiro, Brazil.
Fernanda L Fonseca
Bruno Pontes
Andre Torres
Radames J B Cordero
Rosely M Zancopé-Oliveira
Arturo Casadevall
Nathan B Viana
Leonardo Nimrichter
Marcio L Rodrigues
Eloi S Garcia
Wanderley de Souza
Susana Frases
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRAlbert Einstein College of Medicine · USInstituto Nacional de Metrologia, Qualidade e Tecnologia · BR

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
MOLECULAR CHARACTERIZATION OF C NEOFORMANS ANTIBODIESR01AI033142 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2006
$1.7M
NHLBI NIH HHS HL059842NHLBI NIH HHS R01 HL059842NIAID NIH HHS AI033142NIAID NIH HHS AI033774NIAID NIH HHS AI052733NIAID NIH HHS R01 AI033142NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI052733NIAID NIH HHS R37 AI033142
6 · The paper itself

Abstract

Capsule production is common among bacterial species, but relatively rare in eukaryotic microorganisms. Members of the fungal Cryptococcus genus are known to produce capsules, which are major determinants of virulence in the highly pathogenic species Cryptococcus neoformans and Cryptococcus gattii. Although the lack of virulence of many species of the Cryptococcus genus can be explained solely by the lack of mammalian thermotolerance, it is uncertain whether the capsules from these organisms are comparable to those of the pathogenic cryptococci. In this study, we compared the characteristic of the capsule from the non-pathogenic environmental yeast Cryptococcus liquefaciens with that of C. neoformans. Microscopic observations revealed that C. liquefaciens has a capsule visible in India ink preparations that was also efficiently labeled by three antibodies generated to specific C. neoformans capsular antigens. Capsular polysaccharides of C. liquefaciens were incorporated onto the cell surface of acapsular C. neoformans mutant cells. Polysaccharide composition determinations in combination with confocal microscopy revealed that C. liquefaciens capsule consisted of mannose, xylose, glucose, glucuronic acid, galactose and N-acetylglucosamine. Physical chemical analysis of the C. liquefaciens polysaccharides in comparison with C. neoformans samples revealed significant differences in viscosity, elastic properties and macromolecular structure parameters of polysaccharide solutions such as rigidity, effective diameter, zeta potential and molecular mass, which nevertheless appeared to be characteristics of linear polysaccharides that also comprise capsular polysaccharide of C. neoformans. The environmental yeast, however, showed enhanced susceptibility to the antimicrobial activity of the environmental phagocytes, suggesting that the C. liquefaciens capsular components are insufficient in protecting yeast cells against killing by amoeba. These results suggest that capsular structures in pathogenic Cryptococcus species and environmental species share similar features, but also manifest significant difference that could influence their potential to virulence.

Indexed as

Acanthamoeba castellaniiAnimalsAntibodies, MonoclonalAntigens, FungalBacterial CapsulesBase SequenceCryptococcusElasticityFungal ProteinsHydrodynamicsKineticsLightMolecular Sequence DataMonosaccharidesPhagocytesPhagocytosisAntibodies, MonoclonalAntigens, FungalFungal ProteinsMonosaccharides

Identifiers

PMID22253734
PMCPMC3257238
OpenAlexW2058755496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.